TUESDAY, July 27, 2021 (HealthDay News) — Young people aren’t immune from severe COVID-19, and a new study warns that some are more at risk than others. Folks under 45 have more than triple the risk for severe COVID-19 if they have cancer or heart disease, or blood, neurologic orContinue Reading

TUESDAY, July 27, 2021 (HealthDay News) — There’s been a sharp rise in schizophrenia cases linked with marijuana use since the mid-1990s, a new Danish study finds. Prior research has suggested that marijuana — particularly very heavy use — is associated with an increased risk of schizophrenia. Although strict cause-and-effectContinue Reading

TUESDAY, July 27, 2021 (HealthDay News) — While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound. According to a pair of small new studies, exposing Alzheimer’s patients to an hour a day of carefullyContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading